Why you as a hospital group should join us...​

Innovation in therapies, personalisation, genetics, prevention and early detection have brought laboratory and imaging diagnostics closer together. These shifts are opening up new business models and opportunities for growth along with deeper partnerships especially between speciality providers. This summit is designed to bring together CxOs of imaging and laboratory diagnostics along with investors and explore investment and strategies to continue the transformation of the sector.

In the search for diversified and recurring revenue across all sectors, subscriptions are the go to – from coffee to entertainment and grocery shopping it’s hard to find products and services that aren’t offering a subscription of one form or another. In healthcare, the model has been used in one form or another for many for example Medicover has deployed it for decades but recent hype around Amazon’s One Medical model in the US has generated excitement. Offering access, affordability and convenience to patients seeking a plethora of healthcare services, medicines or wellness products appears to be exactly the Netflix-style disruptive innovation the sector is calling for, but how easy is this model to deploy and maintain? How does it differ from insurance and what are the risks and rewards? This session explores the models being deployed and assesses the strategies, long term impact and scalability of such an approach.

Academic medical centres, particularly big U.S. institutions have spent decades building quality brands, crafting operational best practice, increasing performance and diversifying revenues. For investors seeking to deploy a growing pool of raised capital in a European platform could a partnership between investors and AMCs be a perfect match? This session featuring AMCs and Investors weighs up the potential and explores the value multiple partnership options could bring.

Saudi Arabia’s health transformation programme continues to generate a buzz of excitement from investors and providers, but the moonshot project brings with it a large amount of uncertainty. From service delivery and staffing, logistics, IT and technology to physical infrastructure, clinical research and manufacturing there are opportunities for the entire ecosystem. This session, together with a detailed market overview, brings together providers, investors and key local stakeholders to outline exactly what the opportunity is for outside investment and the best strategies and practice to pursue them

This session recaps the key statements, data-points and lessons learned from HBI 2025, a final chance to record the key takeaways before grabbing a cocktail to celebrate two-days of effective meetings and learning.

Brand is increasingly important in as patients gain, discover and exercise more choice in their healthcare delivery. It is equally crucial to building good cultures, retaining and attracting staff and investment. This session outlines best-practice in building a brand that appeals to patients as a consumer.

A consumer outpatient model like dental, aesthetics or ophthalmology, vet services is seeing strong investor interest. With the emergence of big national and international platforms, how does this sector handle workforce challenges, cost pressure, funding models and digital transformation? adding new over-the counter products and services? This session features investors and vet services groups discussing the opportunities and strategies for growth.

Women spend a disproportionately longer period of their lives in poor health compared to men in large part through systemic and structural barriers, but also because research and funding has tended to be skewed towards men. Closing the Women’s health gap holds enormous economic potential. This session looks at how investment into both sex-specific conditions and understanding how women are affected by general health conditions is closing the gap, the models deployed and the innovation applied.

Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation as national and international groups continue to develop. Governments are increasingly outsourcing cataract operations, new drugs are being approved opening up bigger market potential and providers are developing new products and services to match patient demand. Developing referral and diagnostic pathways from optometry is rapidly improving outcomes and access. In this interactive summit providers, investors and medtech discuss new models in care delivery, the impact of smart equipment and digital disruption and its impact on value creation.